The 2019 Fall CMTA Report

…We Are Family: A Message from CEO Amy Gray Stage Set for Type 2 Breakthroughs New Gene Therapy Development Program for CMT2A Announced CMTA Board Approves Extension of CMT2E Project…

Genetics-of-CMT

CMT subtype Gene HNPP PMP22 (deletion) CMT1A PMP22 (duplication) CMT1B MPZ CMT1C LITAF/SIMPLE CMT1D EGR2 CMT1E PMP22 (point mutation) CMT1X GJB1 (Cx32) CMT2A MFN2 CMT2B RAB7 CMT2D GARS CMT2E NFL…

CMT1A Research Breakthrough!

(CMT1A), the most common form of the disease, accounting for half of all cases. There is currently no treatment or cure for CMT, making the CMT1A research a significant and…

The CMT Exercise Video Series

Created by physiotherapist Rebekah Knight (formerly Lee), the CMT Exercise Video Series focuses on functional improvement for those living with CMT. Part 1: Ankle Balance and Proprioception Part 2: Lower…

Karen Brown, CMTAthlete

…real-life community of support and accountability, I created a Circle of Friends on the CMTA website and asked my friends and family to give to CMT research in support of…

CMT_Fact_Sheet

…development of new drugs to treat CMT, to improve the quality of life for people with CMT, and, ultimately, to find a cure. Our vision is a world without CMT….

CMT Fact sheet_1-2020

…development of new drugs to treat CMT, to improve the quality of life for people with CMT, and, ultimately, to find a cure. Our vision is a world without CMT….

New CEO Takes Helm of the CMTA

Published on December 13, 2018. Last edited by CMTA Admin on June 28, 2019. Amy J. Gray The CMTA Board of Directors announced May 15 the appointment of Amy J….